SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001206774-10-002251
Filing Date
2010-10-29
Accepted
2010-10-29 17:15:29
Documents
5
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT geron_10q.htm 10-Q 582236
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO FORM OF RULE 13A-14(A) exhibit31-1.htm EX-31.1 9687
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO FORM OF RULE 13A-14(A) exhibit31-2.htm EX-31.2 9347
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 exhibit32-1.htm EX-32.1 3758
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 exhibit32-2.htm EX-32.2 3777
  Complete submission text file 0001206774-10-002251.txt   610318
Mailing Address 200 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 101152726
SIC: 2834 Pharmaceutical Preparations